Dr. Pamela L. Alvarez, MD

Dr. Alvarez practices at Valley Neurology in Murrieta, California.

Dr. Alvarez's NPI, 1881627743, was assigned on July 7, 2006. Dr. Alvarez graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1999. Dr. Alvarez holds California license A98180.

Dr. Alvarez's primary practice is Valley Neurology, at 24910 Las Brisas Rd, Murrieta, CA 92562-4010. The practice phone is (951) 698-7366.

Dr. Alvarez's primary practice is Valley Neurology in Murrieta, California. Dr. Alvarez is also affiliated with Southwest Healthcare Rancho Springs Hospital. Dmand AI also links Dr. Alvarez to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alvarez practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Alvarez's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Alvarez's licenses on file in 3 states: California, Washington and Michigan.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, head injury, hereditary polyneuropathy and lower back pain among the conditions Dr. Alvarez treats.

CMS data shows 968 Medicare services from Dr. Alvarez across 12 procedure codes in 2024, for 423 Medicare patients. Medicare paid $107,796 for them.

CMS counts 423 Medicare patients who saw Dr. Alvarez in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alvarez's median patient age at 72, with 60% women.

In 2024, Dr. Alvarez wrote 3,376 Medicare Part D claims for 612 patients. 85% of them were for generic drugs. CMS names the drug for 3,108 of them, across 63 drugs with 11 or more claims each, at $1,127,668 in total drug cost. In 2023, CMS named 2,898 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Alvarez for performance year 2024, reported individually. Dr. Alvarez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alvarez as offering telehealth.

Dmand AI links 5 papers to Dr. Alvarez. The most frequent topics are Hippocampus, Memory and Macaca fascicularis. Dr. Alvarez has published most often in Proc Natl Acad Sci U S A. Dr. Alvarez's most frequent co-author is Macarena Ines De La Fuente, MD.

CMS Open Payments shows 1,484 general payments to Dr. Alvarez from 64 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $4,823.

Dmand AI lists 1 award for Dr. Alvarez, most recently CMS Stage 1 2012 in 2012.

Dr. Alvarez graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1999.

Dr. Alvarez is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.